protein
| receptor of ANGPT1 |
|
HOXA13 directly regulates TEK and FOXF1 in the placental labyrinth endothelia |
|
interacting with ABCG2, ABCC2 (downmodulation of ABCG2 or ABCC2 resulted in the inability of TEK activation to induce a chemoresistant phenotype) |
|
bind to GATA3 |
|
TIE1-TEK interactions are dynamic, inhibitory, and differentially modulated by ANGPT1 and ANGPT2 |
|
ST14 interacts with TEK and degrades the TEK extracellular portion that contains the ligand-binding domain |
|
molecular balance between receptor tyrosine kinases TIE1 and TEK is dynamically controlled by VEGF and TNF and regulates angiopoietin signalling |
|
expression level of TIE1 and its physical interaction with TEK defines whether ANGPT2 functions as a TEK2 agonist or antagonist, thereby determining the context-dependent differential endothelial sensitivity to ANGPT2 |
|
ANGPT1 signaling via the TEK receptor regulates vascular and hematopoietic systems |
|
ligand-independent dimerization of TEK is essential for a strong response upon stimulation with high dose ANGPT1 |
|
under hypoxic conditions, TIE1 is critical for reducing ANGPT1-induced TEK activity and angiogenesis |
|
overexpression of CASP5 can promote the angiogenesis significantly, possibly by inhibiting the ANGPT1/TEK pathway and promoting VEGFA pathway |
|
TEK is essential for venous specification and maintenance via AKT1 mediated stabilization of NR2F2 |